TABLE 2 -.

Cytotoxic activity of the four extracts, doxorubicin and camptothecin, against three cell lines, and normal fibroblast (MTT 72 hours, IC₅₀, μg/mL ±SD, n = 3)

Extract	MCF7	HT29	HepG2	Average* IC50	MRC5
BEP-09	6.00±1.61	8.20±0.57	5.20±0.58	6.47	2.94±0.71
BEP-10	1.85±0.73	5.85±0.23	0.75±0.11**	2.82**	3.34±0.41
BEP-11	16.93±0.66	16.07±0.11	14.07±1.04	15.69	10.77±0.54
BEP-12	16.53±0.43	19.32±0.64	9.60±0.82	15.15	8.72±1.56
Doxorubicin	0.07±0.01	1.98±0.10	2.15±0.15	1.40	5.86±0.35
Camptothecin	0.08±0.01	2.50±0.26	0.76±0.07	1.11	1.18±0.10

*Average cytotoxicity (IC₅₀) of each extract against the three cancer cells. **p ≤ 0.01.